A61K 9/4825
Proteins
Official title: {Proteins, e.g. gelatin (gelatin capsule shells with substantial amounts of other macromolecular substances A61K9/4816)}
A61K9/4825 (Proteins) appears on 815 US grants and 1,510 published applications in this corpus.
Search patents in A61K- Granted patents
- 815
- Published applications
- 1,510
- Assignees
- 584
- Inventors
- 2,376
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 7 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 5 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 2 |
| 2002 | 0 | 8 |
| 2003 | 4 | 9 |
| 2004 | 3 | 14 |
| 2005 | 3 | 14 |
| 2006 | 3 | 8 |
| 2007 | 4 | 17 |
| 2008 | 1 | 22 |
| 2009 | 1 | 15 |
| 2010 | 9 | 31 |
| 2011 | 11 | 30 |
| 2012 | 24 | 51 |
| 2013 | 31 | 49 |
| 2014 | 47 | 85 |
| 2015 | 64 | 85 |
| 2016 | 38 | 85 |
| 2017 | 47 | 106 |
| 2018 | 41 | 84 |
| 2019 | 62 | 94 |
| 2020 | 53 | 100 |
| 2021 | 63 | 92 |
| 2022 | 58 | 103 |
| 2023 | 43 | 110 |
| 2024 | 63 | 137 |
| 2025 | 57 | 93 |
| 2026 | 44 | 66 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Cabozantinib compositions and methods of use22 Sep 2026US 12,741,938 B2Handa Oncology, LLC
- Dopamine receptor d1 agonists and methods of use22 Sep 2026US 12,741,940 B2Mayo Foundation for Medical Education and Research
- Cytokine immunotherapy22 Sep 2026US 12,742,182 B2VLP Therapeutics, LLC
- Chronic kidney disease treatment or prevention method1 Sep 2026US 12,721,844 B2Shionogi & Co., Ltd.
- Production of a pharmaceutical dosage form from horseradish and nasturtium8 Oct 2026US 2026/0306570 A1Kwizda Pharma GmbH
- Cannabidiol formulations1 Oct 2026US 2026/0294812 A1Dsm IP Assets B.V.
- Cosmetic composition for preventing, alleviating or ameliorating alopecia1 Oct 2026US 2026/0294852 A1LG Chem.Ltd.
- Autophagy activator and autophagy activation composition1 Oct 2026US 2026/0294865 A1Maruzen Pharmaceuticals Co., Ltd.
- Coated enteric softgel capsules17 Sep 2026US 2026/0272844 A1R.P. Scherer Technologies, LLC
Most cited
By later US patents
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Chewable, edible soft gelatin capsule305US 4,935,243 APharmacaps, Inc. · 1990
- Inhibitors of brutons tyrosine kinase159US 8,088,781 B2Pharmacyclics, Inc. · 2012
- Stable pharmaceutical composition and methods of using same141US 8,298,554 B2Amarin Pharmaceuticals Ireland Limited · 2012
- Method for forming pharmaceutical capsules from hydrophilic polymers128US 4,738,817 AWarner-Lambert Company · 1988